Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis

Background. Despite the great achievements in the treatment of advanced-stage ovarian cancer, it is still a severe condition with an unfavorable 5-year survival rate. Statins have been suggested to reduce the risk of several cancers beyond their cholesterol-lowing effects. However, the prognostic si...

Full description

Bibliographic Details
Main Authors: Hong-Yu Chen, Qian Wang, Qiu-Hong Xu, Li Yan, Xue-Feng Gao, Yan-Hong Lu, Li Wang
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2016/9125238

Similar Items